• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • INTERACTIVE MAP
  • Location Profiles
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources
Home News & Updates HepVu Welcomes New HepVu Technical Advisory Group

HepVu Welcomes New HepVu Technical Advisory Group

February 2, 2023

ATLANTA – February 2, 2023 HepVu is excited to announce the formation of the HepVu Technical Advisory Group (TAG), which brings together experts in the fields of epidemiology, public health, and healthcare policy and advocacy to provide ongoing technical guidance to the HepVu project. The HepVu TAG was established to give strategic counsel, insight, and guidance on new data as well as potential data development concepts pertaining to viral hepatitis from people with extensive expertise and track records of hands-on work in viral hepatitis surveillance and elimination.

The members of this distinguished committee were welcomed by HepVu leadership at the first HepVu TAG meeting on January 11, 2023, virtually from Washington, DC.

HepVu’s Technical Advisory Group members include:

  • Ben Da, MD, Gastroenterologist, North Shore University Hospital
  • Catherine Freeland, MPH, PhD(c), Associate Director, Public Health Research, Hepatitis B Foundation
  • Prabhu Gounder, MD, MPH, Medical Epidemiologist, LA County Department of Public Health
  • Emalie Huriaux, Integrated Infectious Disease, Hepatitis C, and Drug User Health Programs Manager, Office of Infectious Disease, Division of Disease Control & Health Statistics, Washington State Department of Health
  • Risha Irvin, MD, MPH, Assistant Professor of Medicine, Division of Infectious Diseases; Associate Vice Chair for Diversity and Inclusion, Department of Medicine, Johns Hopkins University of Medicine
  • Kristina Larson, MPH, Hepatitis Surveillance Supervisor, Louisiana Department of Health
  • Lesley Miller, MD, Professor of Medicine, Division of General Internal Medicine; Medical Director, Grady Liver Clinic, Emory University
  • Adrienne Simmons, PharmD, MS, BCPS, AAHIVP, Director of Programs, National Viral Hepatitis Roundtable (NVHR)
  • Lindsey Sizemore, MPH, CPH, Viral Hepatitis Program Director (Epidemiologist III), Tennessee Department of Health
  • Samuel So, MD, Lui Hac Minh Professor and Professor of Surgery, Stanford University School of Medicine; Founder, Stanford Liver Cancer Center; Founder and Executive Director, Asian Liver Center, Stanford University School of Medicine
  • Scott Suckow, Executive Director, Liver Coalition of San Diego
  • Lynn Taylor, MD, FACP, FAASLD, Research Professor, University of Rhode Island
  • Nicola D. Thompson, PhD, Division of Viral Hepatitis, CDC
  • Hansel Tookes, MD, MPH, Founder and Medical Director of IDEA Exchange and Associate Professor in the Division of Infectious Diseases, University of Miami’s Miller School of Medicine

About HepVu

HepVu.org is an online platform that visualizes data and disseminates insights on Hepatitis C and other viral hepatitides in the U.S. to increase awareness of viral hepatitis and inform public health decision-making. HepVu is a Powered By AIDSVu project presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc. In addition to mapping the burden of Hepatitis C at the county- and state-level, HepVu provides users with educational infographics, state-specific factsheets, and downloadable datasets.

Share Facebook Twitter LinkedIn Email

Keep Reading

October 24, 2022

Dr. Heather Bradley and Boatemaa Ntiri-Reid on the Inaugural Viral Hepatitis Surveillance Report

Read More

March 29, 2022

HepVu Partners with NASTAD to Establish Inaugural Viral Hepatitis Surveillance Status Report

Read More

April 25, 2017

Announcing HepVu – A Hepatitis C Surveillance Tool

Read More

February 2, 2023

What's New in Viral Hepatitis - February 2023

Read More

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2025 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.